why choose us

First received: April 03, 2024

Clinical Trial: Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetes Type 2

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Randomized, Multicenter, Double-Blind Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate

Brief Summary: The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and inadequate glycemic control.The study will last about 11 months and may include up to 11 visits.

Read more